Finlay
Institute is a scientific organization dedicated to vaccine research
and production. It is at the service of health; heir and continuer
of a scientific tradition lasting over 100 years. It is internationally
considered one of the most prestigious and recognized in the field.
Makers
and producers of the first and only effective vaccine against Group
B meningococcus (VA-MENGOC-BC®),
this was only the beginning of a great aim in our strategy to find
new pharmaceuticals against diseases for which prophylactic-healing
measures are still missing.
Other work lines
that place Finlay Institute at the forefront of the of the biotechnological
and medical pharmaceutical industry are the production of classic
vaccines included in the Extended Immunization Program (EIP), and
the development of combined vaccines.
You
will have the opportunity to come closer to our institution through
a virtual trip you may undertake in this web, but nothing will substitute
for the unforgettable experience of having direct contact with the
people who make up the Institute, or the satisfaction of being pleased
with the products and services that, from this moment on, are placed
at your disposal.
How
to contact us
Telephone
(53-7) 271-6557, 271-6553
TeleFax
(53-7) 272 0809
Mailing address
POBox 16017, Cod. 11600, Habana, Cuba
Email
General Information
Web
Administrator
| 
